Literature DB >> 7530815

Influence of the neuropeptide galanin on active avoidance in rats.

A A Shandra1, A M Mazarati, K L Servetskii.   

Abstract

It was demonstrated in experiments on rats that the injection of the neuropeptide, galanin (200, 500, and 1000 ng), into the lateral cerebral ventricles induced a dose-dependent decrease in the number of successful attempts at avoidance in rats trained preliminarily to active avoidance by jumping. The preliminary administration of the cholinolytic, atropine (1 mg/kg, intraperitoneally), to the rats also caused an acceleration of the damping of the conditioned reflex and potentiated the indicated effect of galanin during the experiment. The use of the opioid antagonist, naloxone (1 mg/kg, intraperitoneally), did not exert an influence on the animals' behavior, but blocked the galanin-provoked acceleration of the extinction of the active avoidance habit. The intraperitoneal administration of a noncompetitive antagonist of excitatory amino acids, ketamine (10 mg/kg), did not influence the character of the animals' behavior nor the indicated effects of galanin. It was concluded that galanin possesses an amnestic action in the active avoidance test, and that this effect of the peptide is determined by the suppression of cholinergic and activation of opiatergic transmission in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530815     DOI: 10.1007/bf02359796

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  14 in total

1.  Galanin in the medial septal area impairs working memory.

Authors:  B S Givens; D S Olton; J N Crawley
Journal:  Brain Res       Date:  1992-06-05       Impact factor: 3.252

2.  Galanin: an inhibitory neural peptide of the canine small intestine.

Authors:  J E Fox; T J McDonald; F Kostolanska; K Tatemoto
Journal:  Life Sci       Date:  1986-07-14       Impact factor: 5.037

Review 3.  Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia?

Authors:  J N Crawley; G L Wenk
Journal:  Trends Neurosci       Date:  1989-08       Impact factor: 13.837

4.  Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus.

Authors:  P Dutar; Y Lamour; R A Nicoll
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

5.  Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies.

Authors:  G Fisone; C F Wu; S Consolo; O Nordström; N Brynne; T Bartfai; T Melander; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies.

Authors:  Z Wiesenfeld-Hallin; X J Xu; M J Villar; T Hökfelt
Journal:  Neurosci Lett       Date:  1990-02-05       Impact factor: 3.046

7.  Distribution of galanin-like immunoreactivity in the pig, rat and human central nervous system.

Authors:  S R Michener; L D Aimone; T L Yaksh; V L Go
Journal:  Peptides       Date:  1990 Nov-Dec       Impact factor: 3.750

Review 8.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

9.  Galanin attenuates retention of one-trial reward learning.

Authors:  D H Malin; B J Novy; A E Lett-Brown; R E Plotner; B T May; S J Radulescu; M K Crothers; L D Osgood; J R Lake
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

10.  Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence.

Authors:  O Nordström; T Melander; T Hökfelt; T Bartfai; M Goldstein
Journal:  Neurosci Lett       Date:  1987-01-02       Impact factor: 3.046

View more
  3 in total

1.  Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

Authors:  Jefferson W Kinney; Grzegorz Starosta; Andrew Holmes; Craige C Wrenn; Rebecca J Yang; Ashley P Harris; Katharine C Long; Jacqueline N Crawley
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

2.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

Review 3.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.